[go: up one dir, main page]

NO20012540D0 - Use of phosphonomauric acid derivatives for the treatment of infections - Google Patents

Use of phosphonomauric acid derivatives for the treatment of infections

Info

Publication number
NO20012540D0
NO20012540D0 NO20012540A NO20012540A NO20012540D0 NO 20012540 D0 NO20012540 D0 NO 20012540D0 NO 20012540 A NO20012540 A NO 20012540A NO 20012540 A NO20012540 A NO 20012540A NO 20012540 D0 NO20012540 D0 NO 20012540D0
Authority
NO
Norway
Prior art keywords
phosphonomauric
infections
treatment
acid derivatives
derivatives
Prior art date
Application number
NO20012540A
Other languages
Norwegian (no)
Other versions
NO20012540L (en
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of NO20012540D0 publication Critical patent/NO20012540D0/en
Publication of NO20012540L publication Critical patent/NO20012540L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20012540A 1998-11-25 2001-05-23 Use of phosphonomauric acid derivatives for the treatment of infections NO20012540L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854310A DE19854310A1 (en) 1998-11-25 1998-11-25 Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections
PCT/EP1999/008964 WO2000030653A2 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections

Publications (2)

Publication Number Publication Date
NO20012540D0 true NO20012540D0 (en) 2001-05-23
NO20012540L NO20012540L (en) 2001-07-24

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012540A NO20012540L (en) 1998-11-25 2001-05-23 Use of phosphonomauric acid derivatives for the treatment of infections

Country Status (16)

Country Link
EP (1) EP1133302A2 (en)
JP (1) JP2002530343A (en)
CN (1) CN1328464A (en)
AP (1) AP2001002164A0 (en)
AU (1) AU1859100A (en)
BR (1) BR9915605A (en)
CA (1) CA2352511A1 (en)
CZ (1) CZ20011819A3 (en)
DE (1) DE19854310A1 (en)
EA (1) EA200100585A1 (en)
IL (1) IL142775A0 (en)
NO (1) NO20012540L (en)
OA (1) OA11718A (en)
PL (1) PL348354A1 (en)
TR (1) TR200101431T2 (en)
WO (1) WO2000030653A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1408984E (en) 2001-07-20 2008-12-26 Bioagency Ag Organo-phosphorous compounds for activating gamma/delta t cells
CA2518763A1 (en) * 2003-03-14 2004-09-23 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (en) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 Application of the betulic acid in antimycotic biofilm drug is prepared

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (en) * 1993-11-05 1995-05-11 Aktiebolaget Astra Novel amino acid derivatives
SE9604582D0 (en) * 1996-12-13 1996-12-13 Astra Ab Novel compounds
RU2116790C1 (en) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Antiinfectious agent "repharm" for external using
DE19859668A1 (en) * 1998-06-24 1999-12-30 Hassan Jomaa Treating or preventing viral, bacterial, fungal or parasitic infections using bis-phosphonic acid compounds, also having herbicidal activity

Also Published As

Publication number Publication date
WO2000030653A2 (en) 2000-06-02
AP2001002164A0 (en) 2001-06-30
JP2002530343A (en) 2002-09-17
CN1328464A (en) 2001-12-26
NO20012540L (en) 2001-07-24
BR9915605A (en) 2001-08-14
WO2000030653A3 (en) 2000-11-16
AU1859100A (en) 2000-06-13
EP1133302A2 (en) 2001-09-19
TR200101431T2 (en) 2001-10-22
OA11718A (en) 2005-01-26
CZ20011819A3 (en) 2001-12-12
EA200100585A1 (en) 2002-04-25
DE19854310A1 (en) 2000-06-29
PL348354A1 (en) 2002-05-20
IL142775A0 (en) 2002-03-10
CA2352511A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
NO20012995L (en) Compounds useful for the treatment of inflammatory diseases
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
NO20021474L (en) Compounds for the treatment of ischemia
NO20031442L (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
PT956858E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILS FOR THE TREATMENT OF VAGINAL INFECTIONS
NO20022087D0 (en) Procedure for the treatment of diabetes
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20013507L (en) Preparations for the treatment of inflammatory reactions
NO20015288D0 (en) Use of macrolide compounds for the treatment of dry eye
PT1206436E (en) RETINOIDS FOR THE TREATMENT OF ENFISEMA
NO991459D0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
NO20024777D0 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776D0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20020784L (en) Medication for the treatment of fractures
PT1220858E (en) OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
PT1152756E (en) USEFUL ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AUTISM
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20032769D0 (en) Combination method for the treatment of viral infections
NO20012540D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
PT1200447E (en) OXAZINOCARBAZOLES FOR THE TREATMENT OF DISEASES OF THE SNC

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application